Henry Dunnenberger, PharmD

Biography

Dr. Dunnenberger is Assistant Vice President - Personalized Medicine in the Mark R. Neaman Center for Personalized Medicine and Medical Director of the Davis Family Center for Preventive Genomics at Endeavor Health (Endeavor), and leads the various clinical genomics implementation projects, including pharmacogenomics, as the health system. The goal of these projects is to improve the care and health outcomes of Endeavor Health patients through genomic and pharmacogenomics-based strategies. He joined Endeavor in 2014. Dr. Dunnenberger leads the Pharmacogenomics Clinic, which serves as part of a system-wide initiative building upon the health system's strong foundation in genetics and molecular medicine. His clinical expertise and research interests include translating pharmacogenomics into clinical practice, developing information technology solutions for delivering genetic information to both clinicians and patients in a practical manner, and evaluating methods for educating healthcare professionals about pharmacogenetics Dr. Dunnenberger has co-authored over 50 original publications, including multiple CPIC guidelines. He earned his PharmD from the University of Tennessee Health Science Center College of Pharmacy in 2012. He completed a PGY1 Pharmacy Practice Residency at Mission Hospital in Asheville, North Carolina, and a PGY2 Clinical Pharmacogenetics Residency in the Department of Pharmaceutical Sciences at St. Jude Children's Research Hospital in Memphis, Tennessee.